Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 16, 2013
For more info, visit http://www.bio-rad.com/yt/2/QX200-Dro.... Since its introduction two years ago, Droplet Digital PCR has transformed multiple fields of research, including infectious disease, cancer biomarker analysis, and genomic variation analysis. This webinar introduces the concept, workflow, and performance of Droplet Digital PCR and highlights the diverse applications in showcased in recent journal publications.
The QX200™ Droplet Digital PCR system, Bio-Rad's second-generation digital PCR system, provides absolute quantification of target DNA or RNA molecules using EvaGreen or TaqMan hydrolysis probes, yielding unmatched sensitivity and precision for a wide variety of applications.
Presenter: Dr. George Karlin-Neumann, Director of Scientific Affairs, Bio-Rad Digital Biology Center Dr. Karlin-Neumann received his PhD in molecular genetics in 1990 from UCLA. After postdoctoral studies with Dr. Ronald Davis in Stanford's Biochemistry Department, he left in 2001 to cofound ParAllele BioScience, which was acquired by Affymetrix in 2005. Dr. Karlin-Neumann joined QuantaLife in 2010. He has since transitioned to his current role as Director of Scientific Affairs at the Digital Biology Center at Bio-Rad Laboratories, where he is responsible for establishing and over-seeing research collaborations exploring new directions for digital PCR technology.
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.